PHIO Phio Pharmaceuticals Corp

$PHIO Nothing to worry about this. They have one year to prove and get over $1 (including the R/S options). But they don’t need to wait that long, they will rock it with 14 plus points in the next two quarters.🤘🔥

$PHIO Where are imbecile pumpers? Where did they go? Have they crawled back under their stones for their winter sleep? ?? Where are you li'l buddy??

$PHIO continued 2026-08-04 13F Caitong International Asset Management Co., Ltd 6 100.00 0 2026-07-21 13F Nbc Securities, Inc. 0 -100.00 0 -100.00 2026-07-15 13F Spire Wealth Management 1,990 -0.50 2 0.00 2026-06-24 NP DFSTX - U.s. Small Cap Portfolio - Institutional Class 0 -100.00 0 2026-05-28 NP DLHAX - Delaware Healthcare Fund Class A 50,000 0.00 61 17.31 2026-05-28 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares 79,853 61.45 97 90.20 2026-05-15 13F Susquehanna International Group, Llp 0 -100.00 0 -100.00 2026-05-15 13F Bank Of America Corp /de/ 0 -100.00 0 -100.00 2026-05-14 13F Virtu Financial LLC 0 -100.00 0 2026-05-14 13F StoneX Group Inc. 0 -100.00 0 -100.00 2026-05-13 13F DRW Securities, LLC 0 -100.00 0 2026-05-11 13F Citigroup Inc 1,025 1 2026-04-28 13F Robertson Stephens Wealth Management, LLC 0 -100.00 0 -100.00 Showing 1 to 37 of 37 entries

$PHIO if we get a whale this stock is going to ride. A catalyst will light the spark needed to go to $14 and above. It’s tight and long overdue.

$PHIO Executives do not care - if stock goes down just issue themselves more stock. When it is over they can always pivot to Data Centers or some future hot fad. AI is about done since everyone has become an AI company, Data Centers will be passe after midterms, what is the next fad?

$PHIO We may not be able to maintain compliance with the continued listing requirements of The Nasdaq Capital Market. To maintain continued listing on The Nasdaq Capital Market, we must satisfy minimum financial and other requirements. For example, Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2.5 million for continued listing. As of September 30, 2026, our stockholders’ equity was $8.6 million and there can be no assurance that we will be able to maintain or increase our stockholders’ equity in the future. If our stockholders’ equity falls below $2.5 million, as a result of operating losses or for other reasons, or if we are unable to demonstrate to Nasdaq’s satisfaction that we subsequently regained compliance with this requirement, Nasdaq will notify us of such non-compliance.

$PHIO continued 13F Vanguard Capital Management Llc 94,262 18.04 97 -1.03 2026-08-13 13F Northern Trust Corp 27,768 16.88 28 0.00 2026-08-13 13F Vanguard Fiduciary Trust Co 38,169 0.00 39 -15.22 2026-08-13 13F Morgan Stanley 6,000 0.00 6 -14.29 2026-08-12 13F Geode Capital Management, Llc 114,574 -22.19 117 -34.64 2026-08-12 13F Cetera Investment Advisers 47,500 5.56 49 -11.11 2026-08-11 13F Tower Research Capital LLC (TRC) 6,206 -18.56 6 -33.33 2026-08-06 13F Gsa Capital Partners Llp 0 -100.00 0

$PHIO 2026-05-28 NP DLHAX - Delaware Healthcare Fund Class A 50,000 0.00 61 17.31 2026-05-28 NP VEXMX - Vanguard Extended Market Index Fund Investor Shares 79,853 61.45 97 90.20 2026-06-24 NP DFSTX - U.s. Small Cap Portfolio - Institutional Class 0 -100.00 0 2026-07-15 13F Spire Wealth Management 1,990 -0.50 2 0.00 2026-07-21 13F Nbc Securities, Inc. 0 -100.00 0 -100.00 2026-08-04 13F Caitong International Asset Management Co., Ltd 6 100.00 0 2026-08-06 13F Gsa Capital Partners Llp 0 -100.00 0 2026-08-11 13F Tower Research Capital LLC (TRC) 6,206 -18.56 6 -33.33 2026-08-12 13F Geode Capital Management, Llc 114,574 -22.19 117 -34.64 2026-08-12 13F Cetera Investment Advisers 47,500 5.56 49 -11.11 2026-08-13 13F Captrust Financial Advisors 10,000 0.00 10 -16.67 2026-08-13 13F UBS Group AG 5,387 -80.04 6 -84.37